Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 480

1.

Acute exacerbation of chronic osteomyelitis triggered by aggravation of type 2 diabetes mellitus: a case report.

Irie S, Anno T, Kawasaki F, Shigemoto R, Kaneto H, Kaku K, Okimoto N.

J Med Case Rep. 2019 Jan 7;13(1):7. doi: 10.1186/s13256-018-1954-y.

2.

Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study.

Hirukawa H, Kamei S, Kimura T, Obata A, Kohara K, Tatsumi F, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Res. 2018 Nov 7;2018:9435401. doi: 10.1155/2018/9435401. eCollection 2018.

3.

Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon+ α-cells.

Cigliola V, Ghila L, Thorel F, van Gurp L, Baronnier D, Oropeza D, Gupta S, Miyatsuka T, Kaneto H, Magnuson MA, Osipovich AB, Sander M, Wright CEV, Thomas MK, Furuyama K, Chera S, Herrera PL.

Nat Cell Biol. 2018 Nov;20(11):1267-1277. doi: 10.1038/s41556-018-0216-y. Epub 2018 Oct 22.

PMID:
30361701
4.

Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.

Kohara K, Obata A, Kimura T, Shimoda M, Moriuchi S, Okauchi S, Hirukawa H, Mune T, Kaku K, Kaneto H.

Endocr J. 2018 Oct 17. doi: 10.1507/endocrj.EJ18-0203. [Epub ahead of print]

5.

A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report.

Hida M, Anno T, Kawasaki F, Kaneto H, Kaku K, Okimoto N.

J Med Case Rep. 2018 Oct 6;12(1):286. doi: 10.1186/s13256-018-1841-6.

6.

Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic β-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus.

Takai M, Anno T, Kawasaki F, Kimura T, Hirukawa H, Mune T, Okimoto N, Kaku K, Kaneto H.

Intern Med. 2019 Jan 15;58(2):167-173. doi: 10.2169/internalmedicine.1053-18. Epub 2018 Aug 24.

7.

Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.

Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Aug 12. doi: 10.1111/jdi.12909. [Epub ahead of print]

8.

Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity.

Kimura T, Obata A, Shimoda M, Shimizu I, da Silva Xavier G, Okauchi S, Hirukawa H, Kohara K, Mune T, Moriuchi S, Hiraoka A, Tamura K, Chikazawa G, Ishida A, Yoshitaka H, Rutter GA, Kaku K, Kaneto H.

Sci Rep. 2018 Jul 13;8(1):10644. doi: 10.1038/s41598-018-28849-1.

9.

There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.

Kinoshita T, Shimoda M, Sanada J, Fushimi Y, Hirata Y, Irie S, Obata A, Kimura T, Hirukawa H, Kohara K, Tatsumi F, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Ther. 2018 Aug;9(4):1569-1580. doi: 10.1007/s13300-018-0447-8. Epub 2018 Jun 21.

10.

Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.

Shigemoto R, Anno T, Ohnuki E, Kosaka S, Okimoto N, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Nov;9(6):1378-1380. doi: 10.1111/jdi.12796. Epub 2018 Jun 15. No abstract available.

11.

Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.

Kinoshita T, Kamei S, Nakamura Y, Shimoda M, Anno T, Obata A, Kimura T, Hirukawa H, Tatsumi F, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Nov;9(6):1381-1382. doi: 10.1111/jdi.12811. Epub 2018 Jun 15. No abstract available.

12.

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the better.

Kimura T, Obata A, Shimoda M, Okauchi S, Kanda-Kimura Y, Nogami Y, Moriuchi S, Hirukawa H, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Obes Metab. 2018 Oct;20(10):2442-2457. doi: 10.1111/dom.13400. Epub 2018 Jul 5.

PMID:
29873444
13.

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer.

Ishigami K, Nosho K, Koide H, Kanno S, Mitsuhashi K, Igarashi H, Shitani M, Motoya M, Kimura Y, Hasegawa T, Kaneto H, Takemasa I, Suzuki H, Nakase H.

Carcinogenesis. 2018 Sep 21;39(9):1127-1134. doi: 10.1093/carcin/bgy075.

PMID:
29860474
14.

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.

Nakanishi S, Iwamoto M, Kamei S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Kinoshita T, Irie S, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H.

Intern Med. 2018;57(10):1381-1389. doi: 10.2169/internalmedicine.9334-17. Epub 2018 May 15.

15.

Fulminant Type 1 Diabetes Mellitus Complicated with a Life-threatening Electrolyte Abnormality and Abnormal Electrocardiogram Findings.

Kinoshita T, Kaneto H, Kawasaki F, Anno T, Kurihara T, Yamada H, Oshiro Y, Miyashita N, Okimoto N, Kaku K.

Intern Med. 2018 Sep 15;57(18):2685-2688. doi: 10.2169/internalmedicine.0680-17. Epub 2018 Apr 27.

16.

Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase-4 inhibitor vildagliptin.

Anno T, Kaneto H, Kawasaki F, Shigemoto R, Aoyama Y, Kaku K, Okimoto N.

J Diabetes Investig. 2019 Jan;10(1):182-185. doi: 10.1111/jdi.12847. Epub 2018 May 2.

17.

Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.

Kawasaki F, Anno T, Takai M, Irie S, Kaneto H, Kaku K, Okimoto N.

Intern Med. 2018 Aug 15;57(16):2359-2363. doi: 10.2169/internalmedicine.0523-17. Epub 2018 Mar 9.

18.

Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.

Nakanishi S, Iwamoto M, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2019 Jan;10(1):104-107. doi: 10.1111/jdi.12832. Epub 2018 Mar 30.

19.

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.

Kimura T, Obata A, Shimoda M, Hirukawa H, Kanda-Kimura Y, Nogami Y, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Metab. 2018 Jun;44(3):250-260. doi: 10.1016/j.diabet.2017.10.007. Epub 2018 Feb 6.

PMID:
29525225
20.

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.

Kamei S, Iwamoto M, Kameyama M, Shimoda M, Kinoshita T, Obata A, Kimura T, Hirukawa H, Tatsumi F, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Res. 2018 Jan 8;2018:6470137. doi: 10.1155/2018/6470137. eCollection 2018.

Supplemental Content

Loading ...
Support Center